arrow_back Civic Audit
Share share

Recognizing the Role of Accredited Cancer Care Programs

This House Resolution highlights the importance of programs accredited by the American College of Surgeons Commission on Cancer for providing comprehensive and high-quality cancer care. Citizens benefiting from these programs gain access to a wide range of services, from diagnosis to post-treatment support, improving their quality of life and chances of recovery.
Key points
Patients in accredited facilities receive comprehensive care, including access to clinical trials and new treatment options.
Accreditation ensures high quality standards, psychological support, and post-treatment care plans, leading to better cancer treatment outcomes.
Approximately 70% of newly diagnosed cancer patients in the U.S. are treated in accredited programs, underscoring their vital role in healthcare.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 117_HRES_997
Sponsor: Rep. Higgins, Brian [D-NY-26]
Process start date: 2022-03-18
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Recognizing the 100th anniversary of the American College of Surgeons Commission on Cancer and the importance of Commission on Cancer-accredited programs in ensuring comprehensive, high-quality, patient-centered cancer care.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HRES_997.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-03-18.

What are the main provisions?

Key points include:

  • Patients in accredited facilities receive comprehensive care, including access to clinical trials and new treatment options.
  • Accreditation ensures high quality standards, psychological support, and post-treatment care plans, leading to better cancer treatment outcomes.
  • Approximately 70% of newly diagnosed cancer patients in the U.S. are treated in accredited programs, underscoring their vital role in healthcare.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Higgins, Brian [D-NY-26].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health